A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Prescient Therapeutics, Ltd.
SciTech Development, Inc.
Innate Pharma
4SC AG
Kyowa Kirin Co., Ltd.
Genmab
Genmab
Atara Biotherapeutics
Elorac, Inc.
4SC AG
Novartis
Novartis
AbbVie
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Neumedicines Inc.
Merck Sharp & Dohme LLC
Angimmune LLC
Progen Pharmaceuticals
Morphotek
Valerio Therapeutics
INSYS Therapeutics Inc
Emergent Product Development Seattle LLC
Eisai Inc.
Eisai Inc.